Skip to main content
Back
SDGCF logo

Sundrug Co.,Ltd.

Data quality: 100%
Overbought
SDGCF
OTC Healthcare Medical - Pharmaceuticals
$28.18
$0.00 (0.00%)
Mkt Cap: 3.30B
Day Range
$28.18 $28.18
52-Week Range
$28.18 $28.18
Volume
300
50D / 200D Avg
$28.18 / $28.18
Prev Close
$28.18

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 0.1 0.4
P/B 0.0 2.9
ROE % 11.8 3.7
Net Margin % 3.8 3.8
Rev Growth 5Y % 6.0 10.0
D/E 0.1 0.2

Key Takeaways

Revenue grew 6.03% annually over 5 years — modest growth
ROE of 11.76% — decent returns on equity
Debt/Equity of 0.14 — conservative balance sheet
Generating 6.90B in free cash flow
P/E of 0.11 — trading at a low valuation
Capital efficient — spends only 4.27% of revenue on capex

Growth

Revenue Growth (5Y)
6.03%
Revenue (1Y)6.66%
Earnings (1Y)5.58%
FCF Growth (3Y)801.88%

Quality

Return on Equity
11.76%
ROIC10.82%
Net Margin3.84%
Op. Margin5.55%

Safety

Debt / Equity
0.14
Current Ratio1.69
Interest Coverage271.32

Valuation

P/E Ratio
0.11
P/B Ratio0.01
EV/EBITDA-0.52
Dividend Yield0.03%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 6.66% Revenue Growth (3Y) 7.76%
Earnings Growth (1Y) 5.58% Earnings Growth (3Y) 9.38%
Revenue Growth (5Y) 6.03% Earnings Growth (5Y) 4.97%
Profitability
Revenue (TTM) 801.81B Net Income (TTM) 30.75B
ROE 11.76% ROA 6.93%
Gross Margin 25.45% Operating Margin 5.55%
Net Margin 3.84% Free Cash Flow (TTM) 6.90B
ROIC 10.82% FCF Growth (3Y) 801.88%
Safety
Debt / Equity 0.14 Current Ratio 1.69
Interest Coverage 271.32 Dividend Yield 0.03%
Valuation
P/E Ratio 0.11 P/B Ratio 0.01
P/S Ratio 0.00 PEG Ratio 2.89
EV/EBITDA -0.52 Dividend Yield 0.03%
Market Cap 3.30B Enterprise Value -22.99B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 801.81B 751.78B 690.46B 648.73B 634.31B
Net Income 30.75B 29.13B 25.70B 23.85B 25.33B
EPS (Diluted) 262.91 249.07 219.82 204.01 216.63
Gross Profit 204.09B 189.32B 1.29B 1.29B 1.43B
Operating Income 44.50B 41.00B 37.45B 34.05B 37.35B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 444.01B 420.21B 2.72B 2.68B 2.79B
Total Liabilities 174.29B 167.12B 943.78M 864.00M 935.47M
Shareholders' Equity 269.71B 253.09B 236.33B 220.59B 205.16B
Total Debt 38.67B 35.00B 7.07M 4.35M 1.03M
Cash & Equivalents 64.96B 69.70B 80.87B 89.33B 86.50B
Current Assets 216.78B 208.24B 205.91B 199.54B 194.26B
Current Liabilities 128.51B 155.47B 113.25B 96.05B 95.12B

Strategy Scores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#249 of 820
53
Value Defensive Investing (Benjamin Graham)
#464 of 708
20

Recent Activity

Entered Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered Defensive Investing (Benjamin Graham)
Mar 24, 2026